MedDataX Logo

Maternal And Fetal Outcomes in Pregnant Women With Liver Disease

NCT ID: NCT06594237

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

195 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-01

Study Completion Date

2024-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Liver disease complications during pregnancy can impact maternal and neonatal health, though not many studies are on view to investigate maternal and fetal outcomes in Pakistani pregnant women. So, this study was aimed to determine the maternal and fetal outcomes among pregnant females with liver disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure

NCT06872372

Acute Liver Failure Drug-Induced Liver Injury
ACTIVE_NOT_RECRUITING NA

Prognosis of Patients With Acute-on-chronic Liver Failure

NCT05393453

Acute-On-Chronic Liver Failure
UNKNOWN

Frequency of Portal Hypertension Among Patient With Cirrhotic Liver With Ultrasound

NCT07051369

Cirrhosis, Liver
ACTIVE_NOT_RECRUITING

Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy

NCT00433368

Hepatic Encephalopathy
COMPLETED PHASE3

Unknown Cause of Acute Liver Failure

NCT02041637

Liver Failure Unknown Etiology
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fulminant Hepatic Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant females with liver disease
* With gestational age \> 24 weeks
* Any parity or gravidity status

Exclusion Criteria

* Pregnant females with renal disease or any kind of malignancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Muhammad Aamir Latif

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Muhammad Aamir Latif

Research Consultant

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mehnaz Khakwani, FCPS

Role: PRINCIPAL_INVESTIGATOR

Department of Obstetrics & Gynecology, Nishtar Hospital, Multan

Hajra Sultana, FCPS

Role: PRINCIPAL_INVESTIGATOR

Department of Obstetrics & Gynecology, Nishtar Hospital, Multan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nishtar Medical University

Multan, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NishterMultan-2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy
NCT05920213 UNKNOWN PHASE4
Etiology and Prognostic Analysis of Acute Liver Failure in Chinese Children
NCT06778941 NOT_YET_RECRUITING
To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.
NCT02465619 WITHDRAWN
Liver Disease in Pregnancy
NCT03834285 UNKNOWN
Prognostic Significance of Acute Change in Liver and Splenic Stiffness in Patients of Acute on Chronic Liver Failure
NCT06069284 UNKNOWN
To Study the Clinical Course and Outcomes of Non-electively Hospitalised Patients of Chronic Liver Disease (CLD) With Hepatic or Extra-hepatic Predominant Organ Failure(s) at 6 Months.
NCT07270809 NOT_YET_RECRUITING
Acute-On-Chronic Liver Failure in Zagazig University Hospitals
NCT03184636 COMPLETED
Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage
NCT00553423 UNKNOWN PHASE3
Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.
NCT02321371 COMPLETED NA
Effectiveness of Oral Lactulose Versus Lactulose Enema in Hepatic Encephalopathy
NCT05788627 UNKNOWN PHASE4
PEG3350 in ACLF With Hepatic Encephalopathy
NCT03987893 UNKNOWN PHASE4
Prevalence of Liver Dysfunction in Pediatric Patients With Congenital Heart Disease at Assiut.
NCT07144501 NOT_YET_RECRUITING NA
Apoptosis May Have a Role in Etiopathogenesis of Obstetric Cholestasis.
NCT02192177 UNKNOWN
To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites
NCT02649335 COMPLETED PHASE3
High-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure
NCT02718079 COMPLETED NA
Short Term Outcomes in Hospitalized Patients With Liver Cirrhosis
NCT05848414 COMPLETED
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921 RECRUITING
Evaluation of Mechanisms Responsible for Coma in Patients Affected by Fulminant, Acute and Chronic Hepatic Failure
NCT01582087 TERMINATED
Assessment of Coagulation Profile and Haematopoietic Responses in Patients With Acute-on-chronic Liver Failure During Systemic Inflammatory Response (SIRS) and Sepsis
NCT02307409 COMPLETED
Role of 13C Methacetin Breath Test in Predicting Prognosis Among Patients With Acute or Acute on Chronic Liver Failure (ACLF).
NCT01946360 COMPLETED NA
Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-EpidEmiological, Multi-Centre, Study in Patients of PakisTan
NCT02613858 COMPLETED
Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital
NCT06953921 RECRUITING
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
NCT06549673 RECRUITING
To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase
NCT02788240 TERMINATED NA
Neutrophil to Lymphocyte Ratio and Mean Platelet Volume as a Prognostic Predictor Among Patients With Acute on Top of Chronic Liver Cell Failure
NCT06857682 ACTIVE_NOT_RECRUITING